Vistaril and Blood prolactin increased - a phase IV clinical study of FDA data

Summary:

Blood prolactin increased is reported as a side effect among people who take Vistaril (hydroxyzine hydrochloride), especially for people who are female, 20-29 old, also take Levothyroxine Sodium, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Blood prolactin increased when taking Vistaril. It is created by eHealthMe based on reports of 8,641 people who have side effects when taking Vistaril from the FDA, and is updated regularly.

What is Vistaril?

Vistaril has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 9,565 Vistaril users. Check the latest studies of Vistaril.

What is Blood prolactin increased?

Blood prolactin increased is found to be associated with 272 drugs and 529 conditions by eHealthMe. Check the latest studies of Blood prolactin increased.

On Jul, 09, 2026

8,641 people reported to have side effects when taking Vistaril.
Among them, 21 people (0.24%) have Blood prolactin increased.

Could Vistaril cause Blood prolactin increased?

Among these 21 people:

What is the gender of people who have Blood prolactin increased when taking Vistaril? *

female: 80.95 %
male: 19.05 %

What is the age of people who have Blood prolactin increased when taking Vistaril? *

What are other drugs people take besides Vistaril? *

Zyrtec: 5 people, 23.81%
Fenofibrate: 5 people, 23.81%
Montelukast Sodium: 5 people, 23.81%
Metformin: 5 people, 23.81%
Meclizine Hydrochloride: 5 people, 23.81%
Macrobid: 5 people, 23.81%
Loratadine: 5 people, 23.81%
Lipitor: 5 people, 23.81%
Lidocaine: 5 people, 23.81%
Levothyroxine Sodium: 5 people, 23.81%

What are other side effects people have besides Blood prolactin increased? *

Malaise (a feeling of general discomfort or uneasiness): 7 people, 33.33%
Abdominal Discomfort: 5 people, 23.81%
Respiratory Tract Infection: 5 people, 23.81%
Injection Site Reaction: 5 people, 23.81%
Mobility Decreased (ability to move is reduced): 5 people, 23.81%
Infusion Site Swelling: 5 people, 23.81%
Nausea (feeling of having an urge to vomit): 5 people, 23.81%
Weight Decreased: 5 people, 23.81%
Infusion Site Pain: 5 people, 23.81%
Infusion Site Haemorrhage (bleeding from infusion site): 5 people, 23.81%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 5 people, 23.81%
Depression: 5 people, 23.81%
Bipolar Disorder (mood disorder): 5 people, 23.81%
Sleep Disorder: 2 people, 9.52%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 9.52%
Urinary Tract Infection: 1 person, 4.76%
Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 1 person, 4.76%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 4.76%
Psychotic Disorder: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Vistaril and have Blood prolactin increased?

- Check whether Blood prolactin increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vistaril:

Vistaril (9,565 reports)

Browse all side effects of Vistaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood prolactin increased:

Blood prolactin increased (272 drugs)

Browse all the conditions that are associated with Blood prolactin increased:

Blood prolactin increased (529 conditions)

Related publications that referenced our studies

Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyzine hydrochloride (the active ingredients of Vistaril) and Vistaril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.